menu
    • menu

    Company profile for vTv Therapeutics

    NEW Drugs in Dev: 7
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on treating metabolic diseases to minimize their long-term complications through end-organ protection. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines. vTv has an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates for the trea...
    vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on treating metabolic diseases to minimize their long-term complications through end-organ protection. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines. vTv has an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of metabolic diseases and their long term complications such as type 1 diabetes and Alzheimer’s disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    vTv TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3980 Premier Dr. Suite 310 High Point, NC 27265
    Telephone
    Telephone
    (336) 841-0300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vtvtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vtv_therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/vTvTherapeutics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VTv Therapeutics Announces Inducement Grants Under Nasdaq Rules
    VTv Therapeutics Announces Inducement Grants Under Nasdaq Rules

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269637/0/en/vTv-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    VTv Therapeutics at 38th Annual Roth Conference
    VTv Therapeutics at 38th Annual Roth Conference

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256202/0/en/vTv-Therapeutics-to-Participate-in-the-38th-Annual-ROTH-Conference.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    VTv Therapeutics Reveals 2025 Financials, Corporate Update
    VTv Therapeutics Reveals 2025 Financials, Corporate Update

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3253292/0/en/vTv-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    vTv Therapeutics to Participate in Upcoming Investor Conferences
    vTv Therapeutics to Participate in Upcoming Investor Conferences

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238073/0/en/vTv-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    VTV Therapeutics Updates License Deal For PDE4 Inhibitor HPP737
    VTV Therapeutics Updates License Deal For PDE4 Inhibitor HPP737

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230224/0/en/vTv-Therapeutics-Amends-License-Agreement-with-Newsoara-Biopharma-Co-Ltd-for-PDE4-inhibitor-HPP737.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    VTV Therapeutics, M42 Submit Cadisegliatin Phase 2 Protocol in US
    VTV Therapeutics, M42 Submit Cadisegliatin Phase 2 Protocol in US

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3208170/0/en/vTv-Therapeutics-and-M42-s-IROS-Announce-Submission-of-Phase-2-Clinical-Study-Protocol-for-Cadisegliatin-in-Type-2-Diabetes-to-the-United-Arab-Emirates-Department-of-Health.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search